Plain-English translation of NCT04589624 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a new type of MRI scan called hyperpolarized MRI (hpMRI) to see if it can better track how your cancer is responding to treatment. The scan works by injecting a special tracer called hyperpolarized pyruvate into your bloodstream and then taking detailed images. Researchers hope this new scanning method will help doctors understand early on whether your treatment is working.
Current imaging methods sometimes can't show early signs of how well treatment is working, which can delay important treatment decisions. This study exists to see if the new scanning technique can detect changes in your cancer earlier and more accurately than standard imaging.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have an MRI scan lasting about 30 minutes before your cancer treatment starts. During the scan, you'll receive an injection of the special tracer. You'll have a second identical scan about one week after starting your treatment. A doctor will follow up with you one day after your final scan to make sure you're doing well.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States